ADC LINKERS
All chemical linkers are of >95% purity and they are the basic building blocks for a successful ADC. Linkers facilities the conjugation of ADC toxins to antibodies and in the meantime, they also dictate the release mechanism of an ADC.
All chemical linkers are of >95% purity and they are the basic building blocks for a successful ADC. Linkers facilities the conjugation of ADC toxins to antibodies and in the meantime, they also dictate the release mechanism of an ADC.
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
ANTIBODY-DRUG<br />
CONJUGATES<br />
www.creative-biolabs.com/adc<br />
<strong>ADC</strong> <strong>LINKERS</strong><br />
All chemical linkers are of >95% purity and they are the<br />
basic building blocks for a successful <strong>ADC</strong>. Linkers<br />
facilities the conjugation of <strong>ADC</strong> toxins to antibodies<br />
and in the meantime, they also dictate the release<br />
mechanism of an <strong>ADC</strong>.<br />
PODOPHYLLOTOXIN<br />
Creative Biolabs offers highly potent toxins and toxin<br />
derivatives targeting a variety of cellular pathways, including<br />
microtubule assemble and dynamics (microtubule toxins),<br />
DNA biochemistry and structure (DNA toxins), and gene<br />
transcription (transcription toxins) … for antibody-drug<br />
conjugate (<strong>ADC</strong>) development.<br />
POLYKETOMYCIN<br />
<strong>ADC</strong> toxins target crucial intracellular pathways to induce<br />
cell death and they can be over 1000-fold more potent than<br />
chemo therapeutic agents. Creative Biolabs carriers a large<br />
selection of <strong>ADC</strong> toxins ranging from common auristatins,<br />
maytansinoids, calicheamicins to more innovative toxins such<br />
as amatoxins….<br />
CREATIVE BIOLABS<br />
Creative Biolabs is committed to providing high-quality<br />
services to promote the development of <strong>ADC</strong> and other<br />
innovative targeted protein therapeutic agents.
Change language